NEW YORK (GenomeWeb) – Christiana Care announced today that its Gene Editing Institute of the Helen F. Graham Cancer Center & Research Institute has licensed gene-editing technology to Israeli personalized medicine firm NovellusDx as part of an ongoing cancer research collaboration.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.